EXPLORE Health Money Travel Food Style Book Club Classifieds #ZoomerDaily Policy & Perspective Arts & Entertainment Stars & ...

Alcon’s ALC Surgical business continues to gain from its diverse portfolio and incremental innovation. Within Vision Care, the company is registering solid growth, banking on strong sales of its ...

Alcon is a global leader in IOLs and controls 40%-50% of the market, by our estimate. Its AcrySof IQ IOL, which was launched in 1994, has been implanted in more than 135 million eyes, making it ...

EXPLORE Health Money Travel Food Style Book Club Classifieds #ZoomerDaily Policy & Perspective Arts & Entertainment Stars & ...

Alcon is a global leader in IOLs and controls 40%-50% of the market, by our estimate. Its AcrySof IQ IOL, which was launched in 1994, is most implanted IOL in the world. It was the first IOL to be ...

The firm’s analysis indicates that Alcon's end markets, particularly in cataracts and contact lenses, should perform robustly in 2025. The survey of US doctors suggests strong intraocular lens ...

TORONTO, February 27, 2025--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the availability of expanded parameters for TOTAL30 ...

The forthcoming product launches are a testament to Alcon’s commitment to innovation in the field of eye care. The new phacoemulsification machine and the advanced PanOptix AT-IOL are expected ...

CEO David Endicott highlighted 2024 as a strong year for Alcon, with annual sales reaching ... UNITY VCS surgical platform, PanOptix Pro intraocular lens, and the Voyager laser trabeculoplasty ...

Surgical Business Expands: In terms of the latest developments within Implantables, Alcon’s technology continues to lead the market, with every three IOLs (advanced intraocular lenses ...

The forthcoming product launches are a testament to Alcon’s commitment to innovation in the field of eye care. The new phacoemulsification machine and the advanced PanOptix AT-IOL are expected to ...